Szekely Z - Search Results

1

Structure-based design and optimization of a new class of small molecule inhibitors targeting the P-stalk binding pocket of ricin.

Rudolph MJ, Dutta A, Tsymbal AM, McLaughlin JE, Chen Y, Davis SA, Theodorous SA, Pierce M, Algava B, Zhang X, Szekely Z, Roberge JY, Li XP, Tumer NE. Rudolph MJ, et al. Among authors: szekely z. Bioorg Med Chem. 2024 Feb 15;100:117614. doi: 10.1016/j.bmc.2024.117614. Epub 2024 Feb 5. Bioorg Med Chem. 2024. PMID: 38340640 Free article.

2

Design and evaluation of a CXCR4 targeting peptide 4DV3 as an HIV entry inhibitor and a ligand for targeted drug delivery.

Heon Lee I, Palombo MS, Zhang X, Szekely Z, Sinko PJ. Heon Lee I, et al. Among authors: szekely z. Eur J Pharm Biopharm. 2019 May;138:11-22. doi: 10.1016/j.ejpb.2018.06.004. Epub 2018 Jun 9. Eur J Pharm Biopharm. 2019. PMID: 29894816 Free PMC article.

3

Modeling and antitumor studies of a modified L-penetratin peptide targeting E2F in lung cancer and prostate cancer.

Shaik T, Rather GM, Bansal N, Minko T, Garbuzenko O, Szekely Z, Abali EE, Banerjee D, Kerrigan JE, Scotto KW, Bertino JR. Shaik T, et al. Among authors: szekely z. Oncotarget. 2018 Sep 7;9(70):33249-33257. doi: 10.18632/oncotarget.26064. eCollection 2018 Sep 7. Oncotarget. 2018. PMID: 30279956 Free PMC article.

4

Anti-Tumor Effects of a Penetratin Peptide Targeting Transcription of E2F-1, 2 and 3a Is Enhanced When Used in Combination with Pemetrexed or Cisplatin.

Rather GM, Anyanwu M, Minko T, Garbuzenko O, Szekely Z, Bertino JR. Rather GM, et al. Among authors: szekely z. Cancers (Basel). 2021 Feb 26;13(5):972. doi: 10.3390/cancers13050972. Cancers (Basel). 2021. PMID: 33652640 Free PMC article.

5

A Novel Antibody-Toxin Conjugate to Treat Mantle Cell Lymphoma.

Rather GM, Lin SY, Lin H, Szekely Z, Bertino JR. Rather GM, et al. Among authors: szekely z. Front Oncol. 2019 Apr 10;9:258. doi: 10.3389/fonc.2019.00258. eCollection 2019. Front Oncol. 2019. PMID: 31024856 Free PMC article.

6

Responsive foams for nanoparticle delivery.

Tang C, Xiao E, Sinko PJ, Szekely Z, Prud'homme RK. Tang C, et al. Among authors: szekely z. Colloids Surf B Biointerfaces. 2015 Sep 1;133:81-7. doi: 10.1016/j.colsurfb.2015.05.038. Epub 2015 May 27. Colloids Surf B Biointerfaces. 2015. PMID: 26091943 Free PMC article.

7

In cancer, all roads lead to NADPH.

Rather GM, Pramono AA, Szekely Z, Bertino JR, Tedeschi PM. Rather GM, et al. Among authors: szekely z. Pharmacol Ther. 2021 Oct;226:107864. doi: 10.1016/j.pharmthera.2021.107864. Epub 2021 Apr 22. Pharmacol Ther. 2021. PMID: 33894275 Review.

8

Pharmaceutical and toxicological properties of engineered nanomaterials for drug delivery.

Palombo M, Deshmukh M, Myers D, Gao J, Szekely Z, Sinko PJ. Palombo M, et al. Among authors: szekely z. Annu Rev Pharmacol Toxicol. 2014;54:581-98. doi: 10.1146/annurev-pharmtox-010611-134615. Epub 2013 Oct 23. Annu Rev Pharmacol Toxicol. 2014. PMID: 24160695 Free PMC article. Review.

9

Optimal structural design of mannosylated nanocarriers for macrophage targeting.

Chen P, Zhang X, Jia L, Prud'homme RK, Szekely Z, Sinko PJ. Chen P, et al. Among authors: szekely z. J Control Release. 2014 Nov 28;194:341-9. doi: 10.1016/j.jconrel.2014.09.006. Epub 2014 Sep 16. J Control Release. 2014. PMID: 25220160 Free PMC article.

10

Colorectal delivery and retention of PEG-Amprenavir-Bac7 nanoconjugates--proof of concept for HIV mucosal pre-exposure prophylaxis.

Samizadeh M, Zhang X, Gunaseelan S, Nelson AG, Palombo MS, Myers DR, Singh Y, Ganapathi U, Szekely Z, Sinko PJ. Samizadeh M, et al. Among authors: szekely z. Drug Deliv Transl Res. 2016 Feb;6(1):1-16. doi: 10.1007/s13346-015-0269-4. Drug Deliv Transl Res. 2016. PMID: 26712122 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

32 results

Search Page